A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32

Am J Hum Genet. 1999 May;64(5):1378-87. doi: 10.1086/302370.


Autosomal dominant hypercholesterolemia (ADH), one of the most frequent hereditary disorders, is characterized by an isolated elevation of LDL particles that leads to premature mortality from cardiovascular complications. It is generally assumed that mutations in the LDLR and APOB genes account for ADH. We identified one large French pedigree (HC2) and 12 additional white families with ADH in which we excluded linkage to the LDLR and APOB, implicating a new locus we named "FH3." A LOD score of 3.13 at a recombination fraction of 0 was obtained at markers D1S2892 and D1S2722. We localized the FH3 locus to a 9-cM interval at 1p34.1-p32. We tested four regional markers in another set of 12 ADH families. Positive LOD scores were obtained in three pedigrees, whereas linkage was excluded in the others. Heterogeneity tests indicated linkage to FH3 in approximately 27% of these non-LDLR/non-APOB ADH families and implied a fourth locus. Radiation hybrid mapping located four candidate genes at 1p34.1-p32, outside the critical region, showing no identity with FH3. Our results show that ADH is genetically more heterogeneous than conventionally accepted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoproteins B / genetics*
  • Cholesterol, LDL
  • Chromosome Mapping*
  • Chromosomes, Human, Pair 1 / genetics*
  • Female
  • Genetic Markers
  • Humans
  • Hyperlipoproteinemia Type II / genetics*
  • Lod Score
  • Pedigree
  • Receptors, LDL / genetics*


  • Apolipoproteins B
  • Cholesterol, LDL
  • Genetic Markers
  • Receptors, LDL